Friday, July 31, 2015 8:35:57 AM
I would think First Mike knows his stuff when it comes to this science. He and I discuss the potential of this company a lot. He said that the value of KBLB will be valued in the lab. He says the lab will continue to make one product after another which will continue to stun the world and break records. How much do YOU think this is worth? Three cents?
Mike is totally correct. It will be hard to put a price on the value of these feats. Just take a look at DS. This accomplishment is something which was only dreamed of for decades. We have achieved this much to the chagrin of our competition.
You have to look at the reality of what this company has, not at the ridiculous PPS it is sitting at right now. Sales are coming this year, and that means earnings. Once we reach that plateau, the PPS will follow.
So, how much is the potential of KBLB worth. Well, DuPont threw a ton of money away trying to attain spider silk, probably in the billions of dollars. KBLB has gone way beyond that point. At $20.00 a share, a buyout would be valued at roughly 13.7 billion, CHUMP CHANGE FOR A COMPANY LIKE DUPONT.
Imagine only the military uses for KBLB's silks let alone how they will affect just about every industry on earth. This is why KBLB's technology is disruptive, since it will affect just about everything. So, you honestly think KBLB is not worth a minimum of $20.00? You are dreaming!
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM